期刊文献+

肝癌预后miRNA风险评分模型的鉴定和分析 被引量:6

The Identification and Analysis of a miRNA Risk Score Model for Hepatocellular Carcinoma Prognosis
在线阅读 下载PDF
导出
摘要 肝细胞癌(hepatocellular carcinoma,HCC)是世界上高发病率和高死亡率的恶性肿瘤之一.研究目的是寻找HCC相关的mi RNA预后生物学标志物,预测HCC患者的风险程度和生存时间,为他们提供有效的预后信息.使用4种方法从TCGA中识别差异表达的mi RNAs(DEMs).并用Kaplan-Meier生存曲线、单因素和多因素Cox回归分析从DEMs中筛选肝癌预后相关的mi RNA.最终4个HCC的预后mi RNA生物学标志物(hsa-mi R-132-3p、hsa-mi R-139-5p、hsa-mi R-3677-3p、hsa-mi R-500a-3p)被筛选出来组合成一个风险评分模型.目前还没有实验证据表明组合中的hsa-mir-3677-3p与HCC相关,是本研究新发现的mi RNA.生存曲线、ROC曲线、卡方检验等多种生物信息学方法的评价结果均表明,该模型计算出的风险分值能有效预测患者的风险程度(P<0.000,风险比=2.551,95%置信区间=1.751-3.717).低风险组HCC患者1-5年生存率比高风险组高20%-30%.通过与临床数据分析发现,组合的生物学标志物较其他临床指标相比具有更好的预后效果,也可以作为独立的预后因子.最后,预测了4种mi RNA的靶基因,包括AGO2、FOXO1、ROCK2、RAP1B、CYLD等,并在细胞增殖、迁移、凋亡、免疫应答等生物学过程中富集. Hepatocellular carcinoma(HCC)is one of the malignancies with high morbidity and mortality in the world.The purpose of our study was to search for HCC related mi RNA prognostic biomarkers to predict the risk degree and survival time of HCC patients and provide effective prognostic information for HCC patients.Four methods were used to identify differentially expressed mi RNAs(DEMs)from The Cancer Genome Atlas(TCGA).Kaplan-Meier survival curve,univariate and multivariable Cox regression analysis were used to identify prognostic mi RNAs of HCC from DEMs.Four prognostic mi RNAs biomarkers(hsa-mi R-132-3 p,hsa-mi R-139-5 p,hsa-mi R-3677-3 p,hsa-mi R-500 a-3 p)of HCC were identified at last,and combined into a risk score model.There was no experimental evidence that hsa-mir-3677-3 p is related to HCC,and it was a newly discovered mi RNA in this study.The evaluation results of various bioinformatics methods,including survival curve,ROC curve,chi-square test,et al..All indicated that the risk score calculated by the model can effectively predict the risk degree of patients(P<0.000,hazard ratio=2.551,95%confidence interval=1.751-3.717).1-5 year survival rates of HCC patients in the low risk group had 20%-30%higher than in the high risk group.Through the clinical data analysis,it was found that the combined biomarkers have a better prognostic effect than other clinical indicators,and can also be used as an independent prognostic factor.Target genes of four mi RNAs were predicted,including AGO2,FOXO1,ROCK2,RAP1 B,CYLD,et al.,and enriched in biological processes such as cell proliferation,migration,apoptosis and immune response.
作者 门婧睿 谭建军 孙洪亮 MEN Jing-Rui;TAN Jian-Jun;SUN Hong-Liang(College of Life Science and Bioengineering,Beijing University of Technology,Beijing 100124,China)
出处 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2020年第4期344-360,共17页 Progress In Biochemistry and Biophysics
基金 北京市自然科学基金(2202002) 国家自然科学基金(21173014)资助项目.
关键词 MIRNA 肝细胞癌 预后 生物学标志物 TCGA miRNA hepatocellular carcinoma prognosis biomarker TCGA
作者简介 通讯联系人:谭建军.Tel:010-67392001,E-mail:tanjianjun@bjut.edu.cn。
  • 相关文献

参考文献3

二级参考文献206

  • 1Hassan El-Garem,Ayman Ammer,Hany Shehab,Olfat Shaker,Mohammed Anwer,Wafaa El-Akel,Heba Omar.Circulating micro RNA, mi R-122 and mi R-221 signature in Egyptian patients with chronic hepatitis C related hepatocellular carcinoma[J].World Journal of Hepatology,2014,6(11):818-824. 被引量:19
  • 2Caterina Pozzan,Romilda Cardin,Marika Piciocchi,Nora Cazzagon,Gemma Maddalo,Veronica Vanin,Anna Giacomin,Patrizia Pontisso,Umberto Cillo,Fabio Farinati.Diagnostic and prognostic role of SCCA ‐ IgM serum levels in hepatocellular carcinoma ( HCC )[J]. J Gastroenterol Hepatol . 2014 (8)
  • 3Yu Fu,Xufu Wei,Chengyong Tang,Jianping Li,Rui Liu,Ai Shen,Zhongjun Wu.Circulating microRNA?101 as a potential biomarker for hepatitis B virus?relatedhepatocellular carcinoma[J]. Oncology Letters . 2013 (6)
  • 4Verena K?berle,Bernd Kronenberger,Thomas Pleli,J?rg Trojan,Esther Imelmann,Jan Peveling-Oberhag,Martin-Walter Welker,Mohammed Elhendawy,Stefan Zeuzem,Albrecht Piiper,Oliver Waidmann.Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma[J]. European Journal of Cancer . 2013
  • 5Jin Hou,Li Lin,Weiping Zhou,Zhengxin Wang,Guoshan Ding,Qiongzhu Dong,Lunxiu Qin,Xiaobing Wu,Yuanyuan Zheng,Yun Yang,Wei Tian,Qian Zhang,Chunmei Wang,Qinghua Zhang,Shi-Mei Zhuang,Limin Zheng,Anmin Liang,Wenzhao Tao,Xuetao Cao.Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma[J]. Cancer Cell . 2011 (2)
  • 6Jipeng Li,Yiping Wang,Wanjun Yu,Jun Chen,Jianping Luo.Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance[J]. Biochemical and Biophysical Research Communications . 2011 (1)
  • 7Kevin Z. Qu,Ke Zhang,HaiRong Li,Nezam H. Afdhal,Maher Albitar.Circulating MicroRNAs as Biomarkers for Hepatocellular Carcinoma[J]. Journal of Clinical Gastroenterology . 2011 (4)
  • 8Christine Esau,Scott Davis,Susan F. Murray,Xing Xian Yu,Sanjay K. Pandey,Michael Pear,Lynnetta Watts,Sheri L. Booten,Mark Graham,Robert McKay,Amuthakannan Subramaniam,Stephanie Propp,Bridget A. Lollo,Susan Freier,C. Frank Bennett,Sanjay Bhanot,Brett P. Monia.miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting[J]. Cell Metabolism . 2006 (2)
  • 9Rebecca Siegel,Deepa Naishadham,Ahmedin Jemal.Cancer statistics, 2013[J]. CA: A Cancer Journal for Clinicians . 2013 (1)
  • 10Hashem B. El-Serag.Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma[J]. Gastroenterology . 2012 (6)

共引文献166

同被引文献59

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部